Search by Drug Name or NDC
NDC 11673-0627-26 up and up cough plus chest congestion 20; 400 mg/20mL; mg/20mL Details
up and up cough plus chest congestion 20; 400 mg/20mL; mg/20mL
up and up cough plus chest congestion is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 11673-0627-26Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 11673-0627-26Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 11673-0627 |
|---|---|
| Product ID | 11673-627_ed02b906-c131-4b67-88a6-df22fbe16ae7 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | up and up cough plus chest congestion |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dextromethorphan HBr, Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 20; 400 |
| Active Ingredient Units | mg/20mL; mg/20mL |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Labeler Name | Target Corporation |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 11673-0627-26 (11673062726)
| NDC Package Code | 11673-627-26 |
|---|---|
| Billing NDC | 11673062726 |
| Package | 1 BOTTLE in 1 CARTON (11673-627-26) / 118 mL in 1 BOTTLE |
| Marketing Start Date | 2022-10-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |